New Phase 2 Study Set to Evaluate Oral TTI-101 in IPF
January 13, 2023
We use cookies to ensure that we give you the best experience on our website. By using this website you agree to the Privacy Policy and Terms of Use.
Media
Newsroom
2023
2022
2021
These Were the Top 5 Venture Capital Deals in Houston in 2021
December 27, 2021
Special Report: Tvardi Therapeutics Fierce Biotech’s Fierce 15 2021
September 27, 2021
2020
2019
Tvardi Therapeutics CEO Imran Alibhai Talks Biotech
April 10, 2019
Biotech on the Rise
January 2, 2019
2018
Former M.D. Anderson president’s new Houston company names first CEO
December 12, 2018
Tvardi Therapeutics Names Imran Alibhai Chief Executive Officer
December 12, 2018
Tvardi, Co-Founded by Former MD Anderson Leader DePinho, Raises $9M
September 27, 2018
Tvardi Therapeutics, Inc. Secures $9 Million in Series A Financing Round
September 21, 2018
Tvardi Therapeutics raises $9M series A for STAT3 inhibitors
September 20, 2018